查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1287416

人類生長激素市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

市場概況：

全球人類生長激素市場規模在2022年達到53億美元。展望未來，IMARC Group預計到2028年市場規模將達到85億美元，在2023-2028年期間表現出8.1%的成長率（CAGR）。

HGH是一種肽類激素，由腦垂體產生，用於刺激兒童和成人的生長。該激素主要調節細胞的生長、再生、修復、繁殖和代謝，從而促進身體的全面發展。它還調節體液、脂肪代謝以及骨骼和肌肉的生長。 HGH的缺乏會增加疾病和脂肪堆積的風險，而較高的水平會促使兒童的巨人症和成人的肢端肥大症、肌肉萎縮症和短腸症候群。

透納氏症候群和其他與生長有關的疾病的發病率增加是推動市場成長的關鍵因素之一。透納氏症候群是一種主要影響女性的染色體疾病，其特點是X染色體完全或部分喪失。生長激素通常用於扭轉這種疾病的一些症狀，從而增加了全球範圍內對HGH藥物的需求。此外，大眾健康意識的提高和對內分泌失調的預防措施意識的增強，都為市場成長提供了動力。各種疾病，如普拉德-維利症候群（PWS）和特發性身材矮小（ISS），是由體內生長激素的缺乏引起的，可以用醫學合成的HGH來治療。其他因素，包括健美運動員利用HGH作為性能增強劑，以及重組人生長激素（rHGH）的發展，預計將進一步推動市場。

本報告回答的關鍵問題：

  • 迄今為止，全球人類生長激素市場的表現如何，在未來幾年將如何表現？
  • COVID-19對全球人類生長激素市場的影響是什麼？
  • 主要的區域市場是什麼？
  • 基於應用的市場細分是什麼？
  • 基於配銷通路的市場細分是什麼？
  • 基於給藥途徑的市場細分是什麼？
  • 該行業價值鏈的各個階段是什麼？
  • 該行業的關鍵驅動因素和挑戰是什麼？
  • 全球人類生長激素市場的結構是什麼，誰是主要參與者？
  • 該行業的競爭程度如何？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 資料來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球人類生長激素市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按應用分類的市場

  • 生長激素（GH）缺乏症
    • 市場趨勢
    • 主要類型
      • 成人GH缺乏症
      • 兒科GH缺乏症
    • 市場預測
  • 透納氏症候群
    • 市場趨勢
    • 市場預測
  • 特發性身材矮小（ISS）
    • 市場趨勢
    • 市場預測
  • 普威二氏症候群（PWS）
    • 市場趨勢
    • 市場預測
  • 胎兒小於妊娠年齡
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章：按配銷通路分類的市場

  • 醫院藥房
    • 市場趨勢
    • 市場預測
  • 零售藥店
    • 市場趨勢
    • 市場預測
  • 網上藥店
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章：按給藥途徑分類的市場

  • 靜脈注射
    • 市場趨勢
    • 市場預測
  • 肌內註射
    • 市場趨勢
    • 市場預測
  • 皮下注射
    • 市場趨勢
    • 市場預測
  • 口服
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳洲
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章：價值鏈分析

第十二章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：競爭格局

  • 市場結構
  • 主要競爭者
  • 主要競爭者簡介
    • Eli Lilly and Company
    • EMD Serono Inc.
    • F. Hoffmann-La Roche AG
    • Ferring BV
    • Genentech Inc.
    • Ipsen
    • Merck KGaA
    • Novartis AG
    • Novo Nordisk
    • Pfizer Inc.
    • Sandoz
Product Code: SR1623A117_Report

Market Overview:

The global human growth hormone market size reached US$ 5.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

HGH is a peptide hormone that is produced by the pituitary gland to stimulate growth in children and adults. The hormone primarily regulates growth, regeneration, repair, reproduction and metabolism of the cells, thus contributing to the overall development of the body. It also regulates body fluids, fat metabolism and bone and muscle growth. The deficiency of HGH can increase the risk of diseases and fat accumulation, whereas higher levels can cause gigantism in children and acromegaly, muscle-wasting disease and short bowel syndrome in adults.

The increasing prevalence of Turner syndrome and other growth-related disorders is one of the key factors driving the growth of the market. Turner syndrome is a chromosomal disorder that primarily affects females and is characterized by complete or partial loss of X chromosomes. Growth hormones are often administered to reverse some of the symptoms of this disease, thereby increasing the demand for HGH drugs across the globe. Furthermore, increasing health consciousness among the masses and growing awareness regarding the preventive measures against endocrine disorders, are providing a boost to the market growth. Various disorders, such as Prader-Willi syndrome (PWS) and idiopathic short stature (ISS), are caused by the deficiency of growth hormones in the body that can be treated using medically synthesized HGH. Other factors, including a rising utilization of HGH as performance enhancers by bodybuilders, along with the development of recombinant human growth hormone (rHGH), are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global human growth hormone market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on application, distribution channel and route of administration.

Breakup by Application:

  • Growth Hormone (GH) Deficiency
    • Adult GH Deficiency
    • Pediatric GH Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature (ISS)
  • Prader-Willi Syndrome (PWS)
  • Small for Gestational Age
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Breakup by Route of Administration:

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Eli Lilly and Company, EMD Serono Inc., F. Hoffmann-La Roche AG, Ferring B.V., Genentech Inc., Ipsen, Merck KGaA, Novartis AG, Novo Nordisk, Pfizer Inc., Sandoz, etc.

Key Questions Answered in This Report:

  • How has the global human growth hormone market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global human growth hormone market?
  • What are the key regional markets?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the route of administration?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global human growth hormone market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Human Growth Hormone Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Growth Hormone (GH) Deficiency
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Adult GH Deficiency
      • 6.1.2.2 Pediatric GH Deficiency
    • 6.1.3 Market Forecast
  • 6.2 Turner Syndrome
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Idiopathic Short Stature (ISS)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prader-Willi Syndrome (PWS)
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Small for Gestational Age
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Distribution Channel

  • 7.1 Hospital Pharmacy
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Retail Pharmacy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Online Pharmacy
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intramuscular
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Subcutaneous
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Oral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Eli Lilly and Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 EMD Serono Inc.
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 F. Hoffmann-La Roche AG
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 SWOT Analysis
    • 13.3.4 Ferring B.V.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Genentech Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 SWOT Analysis
    • 13.3.6 Ipsen
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
    • 13.3.8 Novartis AG
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
    • 13.3.9 Novo Nordisk
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Pfizer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Sandoz
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio

 

List of Figures

  • Figure 1: Global: Human Growth Hormone Market: Major Drivers and Challenges
  • Figure 2: Global: Human Growth Hormone Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Human Growth Hormone Market: Breakup by Application (in %), 2022
  • Figure 4: Global: Human Growth Hormone Market: Breakup by Distribution Channel (in %), 2022
  • Figure 5: Global: Human Growth Hormone Market: Breakup by Route of Administration (in %), 2022
  • Figure 6: Global: Human Growth Hormone Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Human Growth Hormone Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Human Growth Hormone (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Human Growth Hormone (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Human Growth Hormone (Turner Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Human Growth Hormone (Turner Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Human Growth Hormone (Idiopathic Short Stature- ISS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Human Growth Hormone (Prader-Willi Syndrome- PWS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Human Growth Hormone (Small for Gestational Age) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Human Growth Hormone (Small for Gestational Age) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Human Growth Hormone (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Human Growth Hormone (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Human Growth Hormone (Hospital Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Human Growth Hormone (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Human Growth Hormone (Retail Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Human Growth Hormone (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Human Growth Hormone (Online Pharmacy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Human Growth Hormone (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Human Growth Hormone (Others) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Human Growth Hormone (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Human Growth Hormone (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Human Growth Hormone (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Human Growth Hormone (Intramuscular) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Human Growth Hormone (Intramuscular) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Human Growth Hormone (Subcutaneous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Human Growth Hormone (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Human Growth Hormone (Oral) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Human Growth Hormone (Oral) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia Pacific: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia Pacific: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Human Growth Hormone Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Human Growth Hormone Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Global: Human Growth Hormone Industry: SWOT Analysis
  • Figure 85: Global: Human Growth Hormone Industry: Value Chain Analysis
  • Figure 86: Global: Human Growth Hormone Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Human Growth Hormone Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Human Growth Hormone Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 3: Global: Human Growth Hormone Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 4: Global: Human Growth Hormone Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 5: Global: Human Growth Hormone Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Human Growth Hormone Market: Competitive Structure
  • Table 7: Global: Human Growth Hormone Market: Key Players